Ruimin Hu Selected Research

Ruimin Hu Research Topics

3	Neoplasms (Cancer) 01/2022 - 01/2012
3	Glomerulonephritis 08/2015 - 01/2012
1	Prostatitis 01/2022
1	Neuroblastoma 01/2022
1	Pelvic Pain 01/2022
1	Uveal melanoma 01/2021
1	Hypertension (High Blood Pressure) 12/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2020
1	Nephrosclerosis 12/2020
1	Lymphatic Metastasis 08/2018
1	Lung Neoplasms (Lung Cancer) 08/2018
1	IGA Glomerulonephritis (IGA Nephropathy) 09/2016
1	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2016
1	Pulmonary Hypertension 11/2015
1	Proteinuria 07/2013

2	Proteins (Proteins, Gene)FDA Link 08/2018 - 01/2012
2	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 08/2015 - 07/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 08/2015 - 09/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	micaIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	MLN 8237IBA 01/2022
1	DisintegrinsIBA 01/2022
1	3- (formylhydroxyamino)- 2- (3- phenyl- 1- propyl)butanoic acid (2,2- dimethyl- 1- methylcarbamoyl- 1- propyl)amideIBA 01/2022
1	LigandsIBA 01/2022
1	CateninsIBA 01/2021
1	Complement Factor D (Factor D)IBA 12/2020
1	Antihypertensive Agents (Antihypertensives)IBA 12/2020
1	Complement System Proteins (Complement)IBA 12/2020
1	EnzymesIBA 12/2020
1	Complement Factor B (Factor B)IBA 12/2020
1	Complement Factor H (Factor H)IBA 12/2020
1	Cisplatin (Platino)FDA LinkGeneric 08/2018
1	Biomarkers (Surrogate Marker)IBA 09/2016
1	tanshinoneIBA 11/2015
1	Ubiquitin CIBA 09/2012
1	neonatal Fc receptorIBA 09/2012
1	Deubiquitinating EnzymesIBA 01/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2012
1	DecorinIBA 01/2012
1	Peptide Hydrolases (Proteases)FDA Link 01/2012

2	Drug Therapy (Chemotherapy) 01/2022 - 08/2018
1	Aftercare (After-Treatment) 01/2022